Pharmagest Interactive
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more
Pharmagest Interactive (0R9T) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.191x
Based on the latest financial reports, Pharmagest Interactive (0R9T) has a cash flow conversion efficiency ratio of 0.191x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€45.79 Million) by net assets (€239.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharmagest Interactive - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Pharmagest Interactive's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharmagest Interactive Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmagest Interactive ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OmniAb Inc.
NASDAQ:OABI
|
-0.035x |
|
Shandong Huapeng Glass Co Ltd
SHG:603021
|
0.035x |
|
Shengtak New Material Co Ltd
SHE:300881
|
-0.103x |
|
Mi Technovation Berhad
PINK:MITNF
|
0.026x |
|
Xiangtan Yongda Mach Mnfg Co
SHE:001239
|
N/A |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
0.033x |
|
Jack In The Box Inc
NASDAQ:JACK
|
-0.036x |
|
Avacta Group Plc
PINK:AVCTF
|
-128.776x |
Annual Cash Flow Conversion Efficiency for Pharmagest Interactive (2004–2024)
The table below shows the annual cash flow conversion efficiency of Pharmagest Interactive from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €240.69 Million | €47.55 Million | 0.198x | -26.98% |
| 2023-12-31 | €227.63 Million | €61.59 Million | 0.271x | -6.54% |
| 2022-12-31 | €196.80 Million | €56.98 Million | 0.290x | +0.68% |
| 2021-12-31 | €165.24 Million | €47.52 Million | 0.288x | -9.27% |
| 2020-12-31 | €148.95 Million | €47.21 Million | 0.317x | +2.81% |
| 2019-12-31 | €131.91 Million | €40.66 Million | 0.308x | +25.55% |
| 2018-12-31 | €117.05 Million | €28.74 Million | 0.246x | -5.23% |
| 2017-12-31 | €104.92 Million | €27.19 Million | 0.259x | +18.83% |
| 2016-12-31 | €103.65 Million | €22.60 Million | 0.218x | +0.01% |
| 2015-12-31 | €91.56 Million | €19.96 Million | 0.218x | +6.73% |
| 2014-12-31 | €81.69 Million | €16.69 Million | 0.204x | +26.44% |
| 2013-12-31 | €76.07 Million | €12.29 Million | 0.162x | -40.11% |
| 2012-12-31 | €66.92 Million | €18.05 Million | 0.270x | +12.66% |
| 2011-12-31 | €58.51 Million | €14.01 Million | 0.239x | -0.99% |
| 2010-12-31 | €51.04 Million | €12.35 Million | 0.242x | -7.54% |
| 2007-12-31 | €33.78 Million | €8.84 Million | 0.262x | +41.69% |
| 2006-12-31 | €29.60 Million | €5.46 Million | 0.185x | -50.90% |
| 2005-12-31 | €28.04 Million | €10.54 Million | 0.376x | +14.25% |
| 2004-12-31 | €24.89 Million | €8.19 Million | 0.329x | -- |